Mueller T, Roberts E F, Chen K W. "一种左卡巴斯汀EP杂质L的合成方法" [P]. US Patent, US 9925957 B2, 2021-09-28.
Nielsen H, Sørensen M, Rossi M. "Method for the Synthesis of Levocabastine EP Impurity L" [P]. European Patent, EP 3568676 A1, 2015-08-03.
发明人郭海燕,郑宇鹏,唐晓军. "A Process for Preparing High-Purity Levocabastine EP Impurity L" [P]. 中国发明专利, 专利号 CN 116964993 A, 授权公告日 2016-03-02.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 左卡巴斯汀EP杂质L in Pharmaceutical Formulations". J. Nat. Prod., 2021, 950, 542-572.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 左卡巴斯汀EP杂质L as an Impurity". J. Chromatogr. A, 2011, 680, (10), 9619-9649.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Levocabastine EP Impurity L Using HRMS and NMR". Phytochemistry, 2019, 2422, (5), 3130-3142.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 左卡巴斯汀EP杂质L Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2012, 1634, (2), 5013-5043.